Medicofarma Biotech SA (WSE:MDB)

Medicofarma Biotech Statistics

Total Valuation

WSE:MDB has a market cap or net worth of PLN 21.01 million. The enterprise value is 24.14 million.

Market Cap	21.01M
Enterprise Value	24.14M

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:MDB has 67.98 million shares outstanding.

Current Share Class	67.98M
Shares Outstanding	67.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	10.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	75.21
PB Ratio	3.82
P/TBV Ratio	3.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.53
EV / Sales	86.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.57.

Current Ratio	0.85
Quick Ratio	0.85
Debt / Equity	0.57
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.21

Financial Efficiency

Return on equity (ROE) is -45.19% and return on invested capital (ROIC) is -22.96%.

Return on Equity (ROE)	-45.19%
Return on Assets (ROA)	-15.00%
Return on Invested Capital (ROIC)	-22.96%
Return on Capital Employed (ROCE)	-36.81%
Revenue Per Employee	18,620
Profits Per Employee	-213,813
Employee Count	20
Asset Turnover	0.02
Inventory Turnover	599.14

Taxes

Income Tax	-22,736
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.22% in the last 52 weeks. The beta is 3.24, so WSE:MDB's price volatility has been higher than the market average.

Beta (5Y)	3.24
52-Week Price Change	-44.22%
50-Day Moving Average	0.29
200-Day Moving Average	0.33
Relative Strength Index (RSI)	55.15
Average Volume (20 Days)	12,925

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:MDB had revenue of PLN 279,306 and -3.21 million in losses. Loss per share was -0.05.

Revenue	279,306
Gross Profit	-1.27M
Operating Income	-3.46M
Pretax Income	-3.23M
Net Income	-3.21M
EBITDA	-1.43M
EBIT	-3.46M
Loss Per Share	-0.05

Balance Sheet

The company has 804 in cash and 3.14 million in debt, giving a net cash position of -3.13 million or -0.05 per share.

Cash & Cash Equivalents	804
Total Debt	3.14M
Net Cash	-3.13M
Net Cash Per Share	-0.05
Equity (Book Value)	5.49M
Book Value Per Share	0.08
Working Capital	-712,476

Cash Flow

Operating Cash Flow	-1.52M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-1,238.73%
Pretax Margin	-1,156.41%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

WSE:MDB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-15.27%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 8, 2011. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 8, 2011
Split Type	Reverse
Split Ratio	0.1

Scores

WSE:MDB has an Altman Z-Score of 0.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.01
Piotroski F-Score	2